Westlake Chemical Partners LP (WLKP) · Nov 4, 2026 · Earnings
Beat — EPS $0.46 vs ~$0.30 consensus
Westlake Chemical Partners earnings beat Q3 EPS expectations, while revenue fell short; stronger distributable cash flow lifted coverage to 1.09x.
Westlake Chemical Partners is a yield-oriented ethylene vehicle built around a 22.8% interest in OpCo and a long-term sales agreement that sends most production to Westlake at a fixed cash margin; that contract was already renewed through December 31, 2027, so the core stability story was known before this release.
The quarter beat on per-unit earnings, but not across the income statement. Q3 EPS of $0.46 was well above the published consensus of roughly $0.30, while revenue of $314.5 million missed the roughly $336.3 million expectation. The earnings beat appears to reflect the partnership’s cost structure and cash-flow mechanics more than a broad-based demand surprise.
| Q3 2026 | Q3 2025 | Consensus | |
|---|---|---|---|
| Revenue (Income Statement) | $314.5M (-1.8%) | $308.9M | $336.3M |
| EPS (Income Statement) | $0.46 (+9.5%) | $0.42 | $0.30 |
| EBITDA (EBITDA reconciliation) | $128.3M (+1.8%) | $126.1M | |
| MLP distributable cash flow (DCF reconciliation) | $18.0M (+20.8%) | $14.9M | |
| Coverage ratio (Distribution section) | 1.09x | 1.04x Q2 2026 |
The distribution is better covered, not higher. MLP distributable cash flow rose to $18.0 million, helped by higher production and sales volume plus lower maintenance capital expenditures, and trailing coverage improved to 1.09x from 1.04x. But the quarterly distribution remained $0.4714 per unit, so this strengthens payout protection rather than restarting distribution growth.
The improvement is operationally modest rather than a new growth phase. Net income attributable to the partnership increased $2.0 million sequentially, and EBITDA reached $128.3 million, but the quarter’s revenue was still below expectations and operating cash flow declined sequentially because working-capital changes became less favorable.
Bottom line: This was a mixed earnings release: a clear EPS and coverage beat, offset by a revenue miss and no distribution increase. It modestly reinforces the partnership’s stable-cash-flow story, but it does not materially change the business narrative.⟧
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!